Tech Center 1600 • Art Units: 1677
This examiner grants 59% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17954999 | ASSAYS TO QUANTITATE DRUG AND TARGET CONCENTRATIONS | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 17677255 | STRUCTURE AND METHODS FOR DETECTION OF SAMPLE ANALYTES | Non-Final OA | Nautilus Subsidiary, Inc. |
| 17503122 | ANTIBODY POTENCY ASSAY | Non-Final OA | Genentech, Inc. |
| 17739800 | NANOSTRUCTURE-BASED SENSORS AND METHODS FOR DETECTING ANTIGENS AND ANTIBODIES | Final Rejection | University of Pittsburgh - of the Commonwealth System of Higher Education |
| 18306072 | DEVICES AND METHODS FOR SAMPLE ANALYSIS | Non-Final OA | ABBOTT LABORATORIES |
| 18045845 | METHODS AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF AN ANTI-B-CORONAVIRUS ANTIBODY IN A SAMPLE | Non-Final OA | Abbott Laboratories |
| 17637018 | HIGH-BRIGHTNESS FLUOROPHORES FOR QUANTIFICATION AND PHENOTYPING OF EXTRACELLULAR VESICLES | Non-Final OA | Michigan Technological University |
| 18021662 | TEST KIT WITH IMPROVED SPECIFICITY BY SUPPRESSING FALSE POSITIVES | Final Rejection | Denka Company Limited |
| 17904846 | REAGENTLESS ELECTROCHEMICAL BIOSENSOR | Final Rejection | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO |
| 17631365 | METHODS AND COMPOSITIONS FOR CHARACTERIZING INFLAMMATORY BOWEL DISEASE | Final Rejection | Children's Medical Center Corporation |
| 18253293 | METHODS AND COMPOSITIONS FOR TREATMENT OF RENAL INJURY AND RENAL FAILURE | Non-Final OA | ASTUTE MEDICAL, INC. |
| 18313997 | COMPOSITIONS AND METHODS FOR REMOVAL OF BOUND DETECTION AGENTS | Non-Final OA | VECTOR LABORATORIES, INC. |
| 17636012 | COMPOSITIONS AND METHODS FOR DETECTING AND DEPLETING SAMPLE INTERFERENCES | Non-Final OA | Veravas, Inc. |
| 17793171 | ACTIVITY-SPECIFIC CELL ENRICHMENT | Non-Final OA | ABSCI Corporation |
| 17913363 | METHOD FOR MEASURING FRAGMENTS CONTAINING HUMAN TYPE IV COLLAGEN 7S DOMAIN AND KIT FOR USE THEREIN | Non-Final OA | FUJIREBIO INC. |
| 17790479 | QUANTITATIVE KIT FOR MYXOVIRUS RESISTANCE PROTEIN 1 | Non-Final OA | Beijing Strong Biotechnologies, Inc. |
| 17640828 | MULTIPLY LABELLED PROTEIN FOR DETECTION ASSAYS | Final Rejection | CAMBRIDGE MOLECULAR DIAGNOSTICS LTD |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy